Bloomberg Technology

Future of CRISPR Technology

Innovative Genomics Institute Founder, Nobel Laureate, and CRISPR Co-Founder Jennifer Doudna joins Emily Chang to discuss the future of the CRISPR technology and its commercialization, as well as the biotech industry landscape post-pandemic. She also gives her reaction to UC Berkeley losing the CRISPR patent battle against MIT and Harvard.

Published

3 years ago

on

Innovative Genomics Institute Founder, Nobel Laureate, and CRISPR Co-Founder Jennifer Doudna joins Emily Chang to discuss the future of the CRISPR technology and its commercialization, as well as the biotech industry landscape post-pandemic. She also gives her reaction to UC Berkeley losing the CRISPR patent battle against MIT and Harvard.

Related Topics:

2 Comments

  1. Sir Derty ♦

    March 28, 2022 at 11:26 pm

    It has pros and cons, like anything else…

    Reply

  2. Louis Andreina

    March 28, 2022 at 11:44 pm

    Son unos XX18LIKE.Uno de los mejores conciertos ❤️ Son unos de los mejores conciertos, no puede ir pero de tan solo verlos desde pantalla 9, se que estuvon sorprendente…

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version